Patents by Inventor Leo T. Furcht

Leo T. Furcht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10638734
    Abstract: The present invention relates generally to mammalian multipotent adult stem cells (MASC), and more specifically to methods for obtaining, maintaining and differentiating MASC to cells of multiple tissue types. Uses of MASC in the therapeutic treatment of disease are also provided.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: May 5, 2020
    Assignees: ABT Holding Company, Regents of the University of Minnesota
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 10226485
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: March 12, 2019
    Assignees: ABT Holding Company, Regents of the University of Minnesota
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 10006004
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: June 26, 2018
    Assignee: ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 9974811
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: May 22, 2018
    Assignee: ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 9974810
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: May 22, 2018
    Assignee: ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 9974809
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: May 22, 2018
    Assignee: ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Publication number: 20180110806
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Application
    Filed: October 13, 2017
    Publication date: April 26, 2018
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 9789136
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: October 17, 2017
    Assignees: ABT Holding Company, Regents of the University of Minnesote
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 9526747
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells in cardiac indications.
    Type: Grant
    Filed: November 21, 2011
    Date of Patent: December 27, 2016
    Assignee: Regents of the University of Minnesota
    Inventors: Catherine M. Verfaillie, Morayma Reyes, Leo T. Furcht
  • Publication number: 20150359823
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Application
    Filed: June 8, 2015
    Publication date: December 17, 2015
    Applicants: The Regents of the University of Minnesota, ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Publication number: 20150267167
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Application
    Filed: June 8, 2015
    Publication date: September 24, 2015
    Applicants: The Regents of the University of Minnesota, ABT Holding Company
    Inventors: Leo T. FURCHT, Catherine M. Verfaillie, Morayma Reyes
  • Publication number: 20120064047
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells in cardiac indications.
    Type: Application
    Filed: November 21, 2011
    Publication date: March 15, 2012
    Inventors: Catherine M. Verfaillie, Morayma Reyes, Leo T. Furcht
  • Patent number: 8075881
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells in cardiac indications.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: December 13, 2011
    Assignee: Regents of the University of Minnesota
    Inventors: Catherine M. Verfaillie, Morayma Reyes, Leo T. Furcht
  • Publication number: 20110177595
    Abstract: Methods and compositions are provided for circularizing target sequences in a sample. In particular, ligation oligonucleotides are employed to selectively hybridize with the target such that the target can be ligated into a closed circular target. Rolling circle amplification can then be performed directly on the target sequence for subsequent detection and analysis.
    Type: Application
    Filed: March 7, 2011
    Publication date: July 21, 2011
    Applicants: ABT Holding Company, Regents of the University of Minnesota
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Publication number: 20110171659
    Abstract: The present invention relates generally to mammalian multipotent adult stem cells (MASC), and more specifically to methods for obtaining, maintaining and differentiating MASC to cells of multiple tissue types. Uses of MASC in the therapeutic treatment of disease are also provided.
    Type: Application
    Filed: October 19, 2010
    Publication date: July 14, 2011
    Applicants: ABT HOLDING COMPANY, REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: LEO T. FURCHT, CATHERINE M. VERFAILLIE, MORAYMA REYES
  • Patent number: 7838289
    Abstract: The present invention relates generally to mammalian multipotent adult stem cells (MASC), and more specifically to methods for obtaining, maintaining and differentiating MASC to cells of multiple tissue types. Uses of MASC in the therapeutic treatment of disease are also provided.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: November 23, 2010
    Assignees: ABT Holding Company, Regents of the University of Minnesota
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Patent number: 7659118
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: February 9, 2010
    Assignees: ABT Holding Company, Regents of the University of Minnesote
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Publication number: 20090233354
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Application
    Filed: April 1, 2009
    Publication date: September 17, 2009
    Applicants: The Regents of the University of Minnesota, ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Publication number: 20090233353
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Application
    Filed: April 1, 2009
    Publication date: September 17, 2009
    Applicants: The Regents of the University of Minnesota, ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes
  • Publication number: 20090203129
    Abstract: The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.
    Type: Application
    Filed: April 1, 2009
    Publication date: August 13, 2009
    Applicants: The Regemts of the university of Minnesota, ABT Holding Company
    Inventors: Leo T. Furcht, Catherine M. Verfaillie, Morayma Reyes